Results 131 to 140 of about 7,233,987 (192)

X-Linked Hypophosphatemia

Medicine, 1991
C R, Scriver, H S, Tenenhouse, F H, Glorieux   +2 more
openaire   +2 more sources

Postprandial serum phosphorus and calcium concentrations in adults and children with X-linked hypophosphatemia during burosumab treatment. [PDF]

JBMR Plus
Portale AA, Jan de Beur SM, Munns CF, Peng E, Vincent M, Heerssen HM, Imel EA.   +6 more
europepmc   +1 more source

Targeted Alkaline Phosphatase Therapy Enhances Alveolar Bone Healing in X-Linked Hypophosphatemia in Mice. [PDF]

J Periodontal Res
Phanrungsuwan A, Donnelly B, Millán JL, Foster BL.   +3 more
europepmc   +1 more source

Correction to: Health-related quality of life in French pediatric patients with X-linked hypophosphatemia: real-world data from the International XLH Registry. [PDF]

JBMR Plus
europepmc   +1 more source

Health-related quality of life in French adults with X-linked hypophosphatemia: real-world data from the International XLH Registry. [PDF]

JBMR Plus
Briot K, Lemoine S, Cortet B, Szafors P, Mehsen N, Couture G, Sandilands K, Rylands AJ, Ishii H, Bowden A, Dent JE, Kamenicky P.   +11 more
europepmc   +1 more source

Prevalence of enthesopathies in X-linked hypophosphatemia: an explorative ultrasound study. [PDF]

JBMR Plus
Bachfischer L, Behanova M, Rath E, Meng S, Mittelbach A, Haschka J, Dechat T, Raimann A, Mindler G, Uyanik G, Zwerina J, Kocijan R.   +11 more
europepmc   +1 more source

Delayed diagnosis of X-linked hypophosphatemia in the absence of family history: a global unmet need. [PDF]

JBMR Plus
Uday S, Mughal MZ, Cassinelli H, Florenzano P, Imel EA, Simmons J, Ward LM, Tewari S, Ciğeroğlu O, Li Z, Johnson B, Sandilands K, Carpenter TO.   +12 more
europepmc   +1 more source

X-Linked Hypophosphatemia in a Family Cohort: Clinical Variability, Genetic Confirmation and Modern Therapeutic Perspectives. [PDF]

J Clin Med
Popa O, Balaș M, Golu I, Amzăr D, Dorogi C, Vlad M.   +5 more
europepmc   +1 more source

Burosumab in Chinese adults with X-linked hypophosphatemia: a phase 4 study. [PDF]

JBMR Plus
Liu W, Zhang Z, Wang Y, Pei Y, Xue Y, Ji Y, Sugimoto M, Kuriki M, Xia W.   +8 more
europepmc   +1 more source

Case Report: Increased FGF23 and new insufficiency fractures at burosumab discontinuation in X-linked hypophosphatemia. [PDF]

Front Endocrinol (Lausanne)
Bandir R, Zanisi L, Nicod-Lalonde M, Gonzalez-Rodriguez E.   +3 more
europepmc   +1 more source